Navigation Links
Ono Pharmaceutical Selects Genedata Expressionist for Mass Spectrometry
Date:2/7/2013

Basel (Switzerland) and Tokyo (Japan) (PRWEB) February 07, 2013

Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that Ono Pharmaceutical Co., Ltd.. (Ono) extended its Genedata collaboration with a license of Genedata Expressionist for Mass Spectrometry. Ono is a leading R&D-oriented international pharmaceutical company, which provides treatments for oncological and cardiovascular diseases. The Genedata Expressionist system, an enterprise and comprehensive platform for omics data management, will be used by Ono to further strengthen its targeted proteomics and metabolomics research.

“Our daily research demands accurate mass profiling analysis as well as powerful MRM capabilities for effective quantitative analysis,” noted a spokesperson for the Tsukuba Research Institute at Ono. “Genedata Expressionist for Mass Spectrometry supports our proteomics and metabolomics research with a sophisticated data analysis platform that can process chromatograms ranging from 2MB to over 1GB. And, the system’s ability to integrate data from a variety of instruments is a valuable benefit to us. Finally, with Genedata Expressionist we can rely on superior algorithms that generate clinically relevant biomarkers supporting efficient research processes.”

Experimental designs of molecular profiling studies in the life sciences are continually growing in complexity and size. Genedata Expressionist analyzes and manages genomic, transcriptomics, proteomics, metabolomics, and epigenomics data from leading technologies including next-generation sequencing, high-density microarrays, RT-PCR, and other genomic tools. Additionally, Genedata Expression
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Packaging Machinery Manufacturer, Sepha Ltd.Reports Record Year for Sales of its Visionscan Leak Detection Machine and its Pharmaceutical Deblistering Equipment
2. DelMar Pharmaceuticals Announces Acquisition and $5.4 Million Private Placement to Advance Novel Cancer Therapies
3. Oramed Pharmaceuticals Announces Reverse Stock Split
4. Todays Research on Mylan and Watson Pharmaceuticals: One Drug Makers Sorrow is Another Ones Joy
5. Biscayne Pharmaceuticals Closes $1.5 Million Financing To Advance Recent Discoveries Of Pioneering Endocrine Drug Researcher
6. Eckert & Ziegler Vitalea Science and Korea-based BioCore Bring Human Microdosing to Korea to Address the Needs of the Emergent Pharmaceutical Industry
7. UPM Pharmaceuticals Enhances its Pre-Formulation Capabilities
8. Biosim Pharmaceuticals, Manufacturers of Generic ACTHAR, to Participate at Biotech Showcase 2013
9. Asia-Pacific Active Pharmaceutical Ingredients (APIs) Market Analysis & Forecasts to 2017 in New Research Report @ RnRMarketResearch.com
10. Rafarma Pharmaceuticals, Inc. Achieves Full Certification
11. K-V Pharmaceutical Secures Commitment for $85 Million Loan, Reaches Agreement with Senior Noteholders on Principal Terms of Plan of Reorganization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... Fla. (PRWEB) July 22, 2014 CTD ... for the pharmaceutical, medical device, cosmetics, and other markets, ... Placement with a group of qualified private investors led ... , The transaction involved the signing ... issued 1,725,000 shares of Common Stock at a price ...
(Date:7/22/2014)... Rice Lake Weighing Systems ... NCSL International Workshop and Symposium July 28-31 in ... pressure instrumentation, OIML M1 weights, precision lab weights, ... sets, Essential Weights™. , NCSL International was formed ... solving the common problems faced by measurement and ...
(Date:7/22/2014)... Philadelphia, PA (PRWEB) July 22, 2014 ... Science Center’s Board of Directors at its annual Shareholders ... and Chief Information Officer of The PFM Group, and ... The Science Center also announced the election of Michael ... as Board Vice Chair and Richard P. Jaffe, Esq., ...
(Date:7/22/2014)... (NASDAQ: NEOG ) announced today that revenues ... increased 19% from the previous year to $247,405,000. Fiscal ... year,s $27,190,000. Adjusted for a 3-for-2 stock split effective ... year were $0.76, compared to $0.75 a year ago. ... year established new all-time highs for the 32-year-old company. ...
Breaking Biology Technology:CTD Holdings Closes $1.725 Million Private Placement 2CTD Holdings Closes $1.725 Million Private Placement 3Rice Lake Weighing Systems Showcases Metrology Solutions for the 2014 NCSL International Workshop & Symposium 2Two New Members Elected to University City Science Center Board of Directors 2Two New Members Elected to University City Science Center Board of Directors 3Neogen reports 19% increase in annual revenues 2Neogen reports 19% increase in annual revenues 3Neogen reports 19% increase in annual revenues 4Neogen reports 19% increase in annual revenues 5Neogen reports 19% increase in annual revenues 6Neogen reports 19% increase in annual revenues 7Neogen reports 19% increase in annual revenues 8
... 2012  Berg Diagnostics, a Boston-based molecular diagnostics ... and Certificate of Registration from the Centers ... Clinical Laboratory Improvement Amendment (CLIA).  ... "The achievement of a CLIA certificate ...
... 2012 Incline Therapeutics, Inc., a hospital-focused specialty pharmaceutical ... Officer, and David Socks, President and Chief Operating Officer, ... Health Care Conference on Tuesday, March 6, 2012 at ... About Incline Therapeutics, Inc. Incline ...
... 2012 TREM Rx, Inc., a biotechnology company with a ... announced today the results of an in vivo preclinical study ... the immune system called TREMs (T Resident Effector Memory cells) ... that is far stronger than memory T cells that circulate ...
Cached Biology Technology:Berg Diagnostics Receives CLIA Certification and Launches Novel Vitamin D Assay 2Discovery in Nature elucidates immune cells in skin and supports novel vaccine approach 2Discovery in Nature elucidates immune cells in skin and supports novel vaccine approach 3
(Date:7/22/2014)... engineering professor with an expertise in big data and ... worth more than $600,000 to develop an interactive database ... an associate professor, will lead the project with professor ... and Engineering department. Scientists are compiling and studying data ... genes involved in fruit fly development are commonly found ...
(Date:7/22/2014)... 2014, by lightning from a weather system that moved through ... Stokes Fire, Gold Hikes Fire, French Creek Fire and the ... one larger fire. The fires are burning in timber and ... in size. The present fire situation continues to rapidly ... safety is the priority on the Carlton Complex fires. ...
(Date:7/22/2014)... prevents obesity could be on the horizon. Bacteria ... inhibit weight gain, insulin resistance and other adverse ... University investigators have discovered., "Of course it,s hard ... investigator Sean Davies, Ph.D., assistant professor of Pharmacology. ... consequences of obesity in mice, even though they,re ...
Breaking Biology News(10 mins):UT Arlington big data team wins $600,000 NSF grant to build gene expression database 2Vanderbilt study shows therapeutic bacteria prevent obesity in mice 2
... two closely related species of green algae that practice ... on one route by which evolution gave rise to ... cells. The findings, which indicate that a gene underlying ... during evolution to participate in sex-specific sperm development, are ...
... Quirón Hospital in Donostia-San Sebastián has managed, for the first ... embryonic sex selection in a woman who is a carrier ... ?in order to avoid giving birth to a male child. ... of a degenerative nature. It causes a serious reduction in ...
... combat alpha-1 antitrypsin deficiency, a common hereditary disorder that ... effects in patients and shows signs of being effective, ... trial, researchers evaluated the safety of using a so-called ... - to deliver a corrective gene to 12 patients ...
Cached Biology News:A new male-specific gene in algae unveils an origin of male and female 2Gene therapy for hereditary lung disease advances 2Gene therapy for hereditary lung disease advances 3
Rabbit polyclonal to L Kynurenine ( Abpromise for all tested applications). Antigen: Synthetic peptide L Kynurenine conjugated to a protein carrier. Entrez Gene ID: 8942 Swiss Protein ID...
Rabbit polyclonal to P5 ( Abpromise for all tested applications). entrezGeneID: 10954 SwissProtID: Q14554...
anti-achaete...
P8B1...
Biology Products: